References
Bartalena L, Marcocci C, Bogazzi F et al. Further studies on the course of Graves' ophthalmopathy following radioactive iodine administration. Thyroid 1995; 5 (Suppl. 1): S-70 (abstract 139).
Bartley GB, Fatourechi V, Kadrmas EF et al. The incidence of Graves' ophthalmopathy in Olmsted County, Minnesota. Am J Ophthalmol 1995; 120: 511-517.
Burch HB, Wartofsky L. Graves' ophthalmopathy: current concepts regarding pathogenesis and management. Endocr Rev 1993; 14: 747-793.
de Carli M, D'Elios M, Mariotti S, et al. Cytolytic T cells with Th-1 like cytokine profile predominate in retroorbital lymphocytic infiltrates of Graves' ophthalmopathy. J Clin Endocrinol Metab 1993; 77: 1120- 1124.
Forbes G, Gorman CA, Brennan MD, Gehring DG, Ilstrup DM, Earnest F. Ophthalmopathy of Graves' disease: computerized volume measurements of the orbital fat and muscle. Am J Neuroradiol 1986; 7: 651-656.
Gorman CA. Radioiodine therapy does not aggravate Graves' ophthalmopathy. J Clin Endocrinol Metab 1995; 80:340-342.
Grubeck-Loebenstein B, Trieb K, Sztankay A, Holter W, Anderl H, Wick G. Retrobulbar T cells from patients with Graves' ophthalmopathy are CD8+ and specifically recognize autologous fibroblasts. J Clin Invest 1994; 3: 2738-2743.
Heufelder AE. Pathogenesis of Graves' ophthalmopathy: recent controversies and progress. Europ J Endocrinol 1995; 132: 532-541.
Hofbauer LC, Mühlberg T, K&oouml;nig A, Heufelder AE. Soluble interleukin-1 receptor antagonist serum levels in patients with Graves' ophthalmopathy undergoing orbital radiotherapy. Thyroid 1996; 6 (Suppl. 1): S-99 (abstract 194).
Just M, Kahaly G, Higer H et al. Graves' ophthalmopathy: role of MR imaging in radiotherapy. Radiology 1991; 179: 187-190
Kahaly G, Schuler M, Sewell AC, Bernhard G, Beyer J, Krause U. Urinary glycosaminoglycans in Graves' ophthalmopathy. Clin Endocrinol 1990; 33: 35-44.
Kahaly G, Roesler HP, Lieb W et al. Randomised trial comparing three protocols of orbital radiotherapy in Graves' ophthalmopathy. Thyroid 1996; 6 (Suppl. 1): S-60 (abstract 118).
Kendler DL, Lippa J, Rootman J. The initial characteristics of Graves' orbitopathy vary with age and sex. Arch Ophthalmol 1993; 111: 197-201.
Koornneef L, Schmidt ED, van der Gaag R. The orbit: structure, autoantigens, and pathology. In: Wall JR, How J (eds). Graves' ophthalmopathy. Boston: Blackwell Scientific Publications 1990: 1-16.
Kung AWC, Yau CC, Cheng A. The incidence of ophthalmopathy after radioiodine therapy for Graves' disease: prognostic factors and the role of methimazole. J Clin Endocrinol Metab 1994; 79: 542-546.
McLachlan SM, Prummel MF, Rapoport B. Cell-mediated or humoral immunity in Graves' ophthalmopathy? Profiles of T cell cytokines by polymerase chain reaction from orbital tissue. J Clin Endocrinol Metab 1994; 78: 1070-1074.
Moncayo R, Baldissera I, Decristoforo C, Kendler D, Donnemiller E. Evaluation of immunological mechanisms mediating thyroid-associated ophthalmopathy by raionuclide imaging using the somatostatin analog 111In-octreotide. Thyroid 1997; 7: 21-29.
Mourits Mph, Koornneef L, Wiersinga WM, Prummel MF, Berghout A, van der Gaag RD. Clinical criteria for the assessment of disease activity in Graves' ophthalmopathy: a novel approach. Brit J Ophthalm 1989; 73: 639-644.
Mourits MPh, Prummel MF, Wiersinga WM, Koornneef L. Measuring eye movements in Graves' ophthalmopathy. Ophthalmology 1994; 101: 1341-1346.
Nugent RA, Spinelli J, Graeb DA. Graves' orbitopathy: correlation of CT an clinical findings. Radiology 1990; 177: 675-682.
Perros P, Cromble AL, Matthews JNS, Kendall-Taylor P. Age and gender influence the severity of thyroid-associated ophthalmopathy: a study of 101 patients attending a combined thyroid-eye clinic. Clin Endocrinol 1993; 38: 367-372.
Perros P, Cromble AL, Kendall-Taylor P. Natural history of thyroid associated ophthalmopathy. Clin Endocrinol 1995; 42: 45-50.
Pinchera A, Wiersinga WM, Glinoer D et al. Classification of eye changes of Graves' disease. Thyroid 1992; 2: 235-236.
Polak BCP, Wijngaarde R. Radiation retinopathy in patients with both diabetes mellitus and ophthalmic Graves' disease. Orbit 1995; 14: 71-74.
Postema PTE, Krenning EP, Wijngaarde R, et al. [111In-DTPA-D-Phe1]Octreotide scintigraphy in thyroidal and orbital Graves' disease: a parameter for disease activity? J Clin Endocrinol Metab 1994; 79: 1845-1851.
Prummel MF, Wiersinga WM, Mourits MPh, Koornneef L, Berghout A, van der Gaag R. Amelioration of eye changes of Graves' ophthalmopathy by achieving euthyroidism. Acta Endocrinol 1989; 121 (Suppl 2): 185-189.
Prummel MF, Wiersinga WM, Mourits MPh, Koornneef L, Berghout A, van der Gaag R. Effect of abnormal thyroid function on the severity of Graves' ophthalmopathy. Arch Int Med 1990; 150: 1098- 1101.
Prummel MF, Wiersinga WM. Smoking and risk of Graves' disease. JAMA 1993; 269: 479-482.
Prummel MF, Suttorp-Schulten MSA, Wiersinga WM, Verbeek AM, Murits MPh, Koornneef L. A new ultrasonographic method to detect disease activity and predict response to immunosuppressive treatment in Graves' ophthalmopathy. Ophthalmology 1993; 100: 556-561.
Prummel MF, Mourits MPh, Blank L, Berghout A, Koornneef L, Wiersinga WM. Randomised double- blind trial of prednisone versus radiotherapy in Graves' ophthalmopathy. Lancet 1993; 342: 949-954.
Spitzweg C, Joba W, Hunt N, Heufelder AE. Analysis of human thyrotropin receptor gene expression and immunoreactivity in human orbital tissue. Europ J Endocrinol 1997; 136: 599-607.
Sridama V, DeGroot LJ. Treatment of Graves' disease and the course of ophthalmopathy. Am J Med 1989; 87: 70-73.
Tallstedt L, Lundell G, T&oouml;rring O et al. Occurrence of ophthalmopathy after treatment for Graves' hyperthyroidism. New Engl J Med 1992; 326: 1733-1738.
Tallstedt L, Lundell G, Blomgren H, Bring J. Does early administration of thyroxine reduce the devlopment of Graves' ophthalmopathy after radioiodine treatment? Europ J Endocrinol 1994; 130: 494- 497.
Weetman AP. Thyroid-associated eye disease: pathophysiology. Lancet
1991; 338: 25-28. Wiersinga WM. Advances in medical therapy of thyroid-associated ophthalmopathy.
Orbit 1996; 15: 177- 186.
Winsa B, Rastad J, Ċöm G, Johansson H, Westermark K, Karlsson
FA. Retrospective evaluation of subtotal and total thyroidectomy in Graves'
disease with and without endocrine ophthalmopathy. Europ J Endocrinol 1995;
132: 406-412.